checkAd
    Startseite > Aktien > Eton Pharmaceuticals > Nachrichten
    Eton Pharmaceuticals Aktie
    3,7100
     
    USD
    -1,07 %
    -0,0400 USD
    Letzter Kurs 04.05.24 Nasdaq
    3,7000
     
    USD
    9.500 STK
    Geldkurs 03.05.24
    3,7800
     
    USD
    400 STK
    Briefkurs 03.05.24
    ISIN: US29772L1089 · WKN: A2N38G · SYM: ETON · USA

    Neueste Nachrichten

    Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
    01.05.24 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
    30.04.24 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
    29.04.24 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE for Phenylketonuria
    22.03.24 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
    14.03.24 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
    29.02.24 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
    21.02.24 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
    02.02.24 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
    09.11.23 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
    30.10.23 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
    04.10.23 · globenewswire · Eton Pharmaceuticals
    Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    23.08.23 · globenewswire · Eton Pharmaceuticals